Millennium Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-19,908
| Closed | -$111K | – | 6874 |
|
|
2022
Q4 | $111K | Sell |
19,908
-69,367
| -78% | -$408K | ﹤0.01% | 5548 |
|
|
2022
Q3 | $593K | Buy |
89,275
+31,618
| +55% | +$256K | ﹤0.01% | 4813 |
|
|
2022
Q2 | $574K | Buy |
57,657
+57,394
| +21,823% | +$548K | ﹤0.01% | 4840 |
|
|
2022
Q1 | $5K | Sell |
263
-8,085
| -97% | -$127K | ﹤0.01% | 6784 |
|
|
2021
Q4 | $148K | Sell |
8,348
-16,500
| -66% | -$494K | ﹤0.01% | 6080 |
|
|
2021
Q3 | $921K | Sell |
24,848
-15,818
| -39% | -$702K | ﹤0.01% | 4779 |
|
|
2021
Q2 | $2.42M | Sell |
40,666
-13,564
| -25% | -$822K | ﹤0.01% | 3729 |
|
|
2021
Q1 | $3.63M | Buy |
54,230
+50,950
| +1,553% | +$3.99M | ﹤0.01% | 2941 |
|
|
2020
Q4 | $198K | Buy |
3,280
+762
| +30% | +$52K | ﹤0.01% | 4815 |
|
|
2020
Q3 | $199 | Sell |
2,518
-12,713
| -83% | -$1.01M | ﹤0.01% | 4075 |
|
|
2020
Q2 | $952K | Buy |
+15,231
| New | +$887K | ﹤0.01% | 3027 |
|
|
2019
Q4 | – | Sell |
-365
| Closed | -$66K | – | 4648 |
|
|
2019
Q3 | $66K | Sell |
365
-2,572
| -88% | -$363K | ﹤0.01% | 4016 |
|
|
2019
Q2 | $382K | Sell |
2,937
-64,610
| -96% | -$11.6M | ﹤0.01% | 3406 |
|
|
2019
Q1 | $16.4M | Buy |
67,547
+10,572
| +19% | +$2.8M | 0.02% | 919 |
|
|
2018
Q4 | $10.9M | Buy |
56,975
+48,725
| +591% | +$11.9M | 0.02% | 1083 |
|
|
2018
Q3 | $2.71M | Buy |
+8,250
| New | +$2.53M | ﹤0.01% | 2214 |
|
|
2017
Q4 | – | Sell |
-2,692
| Closed | -$712K | – | 4083 |
|
|
2017
Q3 | $712K | Buy |
+2,692
| New | +$778K | ﹤0.01% | 2680 |
|
|
2017
Q2 | – | Sell |
-16,826
| Closed | -$6.06M | – | 3881 |
|
|
2017
Q1 | $6.06M | Sell |
16,826
-35,096
| -68% | -$10.9M | 0.01% | 1338 |
|
|
2016
Q4 | $15M | Buy |
51,922
+34,615
| +200% | +$10.7M | 0.03% | 711 |
|
|
2016
Q3 | $5.89M | Buy |
17,307
+9,861
| +132% | +$3.6M | 0.01% | 1236 |
|
|
2016
Q2 | $3.16M | Sell |
7,446
-14,914
| -67% | -$6.15M | 0.01% | 1538 |
|
|
2016
Q1 | $7.16M | Sell |
22,360
-14,208
| -39% | -$4.85M | 0.02% | 1033 |
|
|
2015
Q4 | $19M | Sell |
36,568
-3,885
| -10% | -$1.43M | 0.04% | 598 |
|
|
2015
Q3 | $11.9M | Sell |
40,453
-12,155
| -23% | -$4.32M | 0.02% | 837 |
|
|
2015
Q2 | $20.7M | Buy |
52,608
+82
| +0.2% | +$28.9K | 0.04% | 613 |
|
|
2015
Q1 | $15.9M | Buy |
52,526
+7,854
| +18% | +$1.92M | 0.03% | 786 |
|
|
2014
Q4 | $9.94M | Sell |
44,672
-948
| -2% | -$196K | 0.02% | 993 |
|
|
2014
Q3 | $10.6M | Buy |
45,620
+4,720
| +12% | +$1.19M | 0.03% | 835 |
|
|
2014
Q2 | $9.04M | Sell |
40,900
-3,200
| -7% | -$712K | 0.03% | 872 |
|
|
2014
Q1 | $13.9M | Buy |
44,100
+7,660
| +21% | +$2.44M | 0.04% | 621 |
|
|
2013
Q4 | $9.49M | Sell |
36,440
-1,190
| -3% | -$261K | 0.03% | 752 |
|
|
2013
Q3 | $5.51M | Buy |
37,630
+4,230
| +13% | +$511K | 0.02% | 1060 |
|
|
2013
Q2 | $5.06M | Buy |
+33,400
| New | +$4.58M | 0.02% | 1012 |
|
Other funds holding TXMD
RCMNY
CC
TC
SSP
BCM
Millennium Management's TXMD Position: Q1 2023 in Review
Millennium Management sold out of TherapeuticsMD (TXMD) in Q1 2023, closing a stake of 19,908 shares — an estimated $111K sold.
Millennium Management first reported a position in TXMD in Q2 2013 and held it in 33 quarters. The position peaked at $20.7M in Q2 2015. 41 funds tracked by Wall St. Rank hold TXMD as of Q1 2023.
- Millennium Management reported no remaining TherapeuticsMD position as of Q1 2023 after selling out during the quarter.
- Millennium Management sold 19,908 TherapeuticsMD shares in Q1 2023, an estimated $111K.
- Millennium Management first reported a position in TherapeuticsMD in Q2 2013 and held it in 33 quarters.
- Millennium Management's TherapeuticsMD position peaked at $20.7M in Q2 2015.
- 41 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2023.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.